---
title: "Wanchen Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 472 million yuan, an increase of 50,358.8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255081845.md"
description: "According to the Zhitong Finance APP, Wanchen Biotechnology released its semi-annual report for 2025, showing an operating income of 22.583 billion yuan, a year-on-year increase of 106.89%. The net profit attributable to shareholders of the listed company was 472 million yuan, a year-on-year increase of 50,358.80%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 451 million yuan. The basic earnings per share were 2.62 yuan"
datetime: "2025-08-28T22:01:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255081845.md)
  - [en](https://longbridge.com/en/news/255081845.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255081845.md)
generator: "portal-rs"
---

# Wanchen Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 472 million yuan, an increase of 50,358.8%

According to the Zhitong Finance APP, Wanchen Biotechnology (300972.SZ) released its semi-annual report for 2025, showing an operating income of 22.583 billion yuan, a year-on-year increase of 106.89%. The net profit attributable to shareholders of the listed company was 472 million yuan, a year-on-year increase of 50,358.80%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 451 million yuan. The basic earnings per share were 2.62 yuan

### Related Stocks

- [300972.CN](https://longbridge.com/en/quote/300972.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Mesothelioma Hope Interviews MD Anderson Oncologist Dr. Kanwal Raghav on Immunotherapy Advances and the Future of Peritoneal Mesothelioma Treatment](https://longbridge.com/en/news/296928731.md)
- [07:47 ETUnreal Engine 5: The Future of Entropia Universe is Coming Soon](https://longbridge.com/en/news/296909012.md)
- [14:34 ETExcelsior Ambulance Appoints Marvin McLellan as Chief Executive Officer](https://longbridge.com/en/news/296947049.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**